Phenotype Varies for Presumed Pathogenic Variants in KCNB1

Share this content:
Phenotype Varies for Presumed Pathogenic Variants in <i>KCNB1</i>
Phenotype Varies for Presumed Pathogenic Variants in KCNB1

WEDNESDAY, Aug. 16, 2017 (HealthDay News) -- De novo KCNB1 missense and loss-of-function variants are associated with neurodevelopmental disorders, with or without seizures, according to a study published online Aug. 14 in JAMA Neurology.

Carolien G.F. de Kovel, Ph.D., from the University Medical Center in Utrecht, Netherlands, and colleagues examined the clinical spectrum associated with KCNB1 variants. Variants were identified with massive parallel sequencing and confirmed with Sanger sequencing. In all families except one, absence of the variant in the parents could be confirmed with Sanger sequencing.

The researchers found that 20 of the 26 patients with developmental delay carried a missense variant in the ion channel domain of KCNB1, with a concentration of variants in region S5 to S6. Three variants that led to premature stops were located in each of the C-terminal and the ion channel domain. Overall, 21 of 25 patients had seizures, and nine started with epileptic spasms between age 3 and 18 months. All of the patients had developmental delay, with 65 percent experiencing severe developmental delay. Fourteen of the 17 with severe developmental delay had behavioral problems. In four of six patients with stop variants and in a patient with a variant in the S2 transmembrane element rather than the S4 to S6 region, developmental delay was milder.

"The type and position of the variants in the protein are (imperfectly) correlated with the severity of the disorder," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Wait Times Have Improved in VA Health Care System

Wait Times Have Improved in VA Health Care ...

Wait times similar to private sector in 2014 but shorter overall and in some specialties in 2017

Medication Treatment for Substance Abuse Up in Facilities

Medication Treatment for Substance Abuse Up in Facilities

2007 to 2016 saw increase in use of medication treatment, reaching 36.1 percent in 2016

Mindfulness, Stress Linked to Menopausal Symptoms

Mindfulness, Stress Linked to Menopausal Symptoms

Link between mindfulness and symptoms more robust in women experiencing higher stress

is free, fast, and customized just for you!




Already a member?

Sign In Now »